Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia

Fig. 5

The effect of TSC22D3 expression on AML. A The effect of TSC22D3 expression on OS of 173 adult AML patients. B The effect of TSC22D3 expression on OS of 100 adult AML patients in the chemotherapy group. C The effect of TSC22D3 expression on OS of 73 adult AML patients in the transplantation group. D The effect of TSC22D3 expression on EFS of 171 adult AML patients. E The effect of TSC22D3 expression on EFS of 98 adult AML patients in the chemotherapy group. F The effect of TSC22D3 expression on EFS of 73 adult AML patients in the transplantation group. G The effect of TSC22D3 expression on drug response using the CGP dataset of the CARE database. H The effect of TSC22D3 expression on drug response using the CTRP dataset of the CARE database

Back to article page